Tuberculosis Diagnostics-EMEA Market Status and Trend Report 2013-2023
Report Summary
Tuberculosis Diagnostics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Tuberculosis Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Tuberculosis Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Tuberculosis Diagnostics in EMEA, with company and product introduction, position in the Tuberculosis Diagnostics market
Market status and development trend of Tuberculosis Diagnostics by types and applications
Cost and profit status of Tuberculosis Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the EMEA Tuberculosis Diagnostics market as:
EMEA Tuberculosis Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Tuberculosis Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Smear Microscopy
LF-LAM For PLHIV
Culture
Molecular Testing
Drug Susceptibility Testing
Mantoux Tuberculin Testing
EMEA Tuberculosis Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Diagnostic laboratories
EMEA Tuberculosis Diagnostics Market: Players Segment Analysis (Company and Product introduction, Tuberculosis Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories
Becton, Dickinson and Company
Alere, Inc.
BioMerieux SA
F.Hoffmann-La Roche AG
Thermo Fisher Scientific
Siemens
Cepheid
Akonni Biosystems
Hain Lifesciences GmBH
NanoEnTe
Hologic Corporation
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Tuberculosis Diagnostics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Tuberculosis Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Tuberculosis Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Tuberculosis Diagnostics in EMEA, with company and product introduction, position in the Tuberculosis Diagnostics market
Market status and development trend of Tuberculosis Diagnostics by types and applications
Cost and profit status of Tuberculosis Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the EMEA Tuberculosis Diagnostics market as:
EMEA Tuberculosis Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Tuberculosis Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Smear Microscopy
LF-LAM For PLHIV
Culture
Molecular Testing
Drug Susceptibility Testing
Mantoux Tuberculin Testing
EMEA Tuberculosis Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Diagnostic laboratories
EMEA Tuberculosis Diagnostics Market: Players Segment Analysis (Company and Product introduction, Tuberculosis Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories
Becton, Dickinson and Company
Alere, Inc.
BioMerieux SA
F.Hoffmann-La Roche AG
Thermo Fisher Scientific
Siemens
Cepheid
Akonni Biosystems
Hain Lifesciences GmBH
NanoEnTe
Hologic Corporation
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF TUBERCULOSIS DIAGNOSTICS
1.1 Definition of Tuberculosis Diagnostics in This Report
1.2 Commercial Types of Tuberculosis Diagnostics
1.2.1 Smear Microscopy
1.2.2 LF-LAM For PLHIV
1.2.3 Culture
1.2.4 Molecular Testing
1.2.5 Drug Susceptibility Testing
1.2.6 Mantoux Tuberculin Testing
1.3 Downstream Application of Tuberculosis Diagnostics
1.3.1 Hospital
1.3.2 Diagnostic laboratories
1.4 Development History of Tuberculosis Diagnostics
1.5 Market Status and Trend of Tuberculosis Diagnostics 2013-2023
1.5.1 EMEA Tuberculosis Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Tuberculosis Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Tuberculosis Diagnostics in EMEA 2013-2017
2.2 Consumption Market of Tuberculosis Diagnostics in EMEA by Regions
2.2.1 Consumption Volume of Tuberculosis Diagnostics in EMEA by Regions
2.2.2 Revenue of Tuberculosis Diagnostics in EMEA by Regions
2.3 Market Analysis of Tuberculosis Diagnostics in EMEA by Regions
2.3.1 Market Analysis of Tuberculosis Diagnostics in Europe 2013-2017
2.3.2 Market Analysis of Tuberculosis Diagnostics in Middle East 2013-2017
2.3.3 Market Analysis of Tuberculosis Diagnostics in Africa 2013-2017
2.4 Market Development Forecast of Tuberculosis Diagnostics in EMEA 2018-2023
2.4.1 Market Development Forecast of Tuberculosis Diagnostics in EMEA 2018-2023
2.4.2 Market Development Forecast of Tuberculosis Diagnostics by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Tuberculosis Diagnostics in EMEA by Types
3.1.2 Revenue of Tuberculosis Diagnostics in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Tuberculosis Diagnostics in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Tuberculosis Diagnostics in EMEA by Downstream Industry
4.2 Demand Volume of Tuberculosis Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Tuberculosis Diagnostics by Downstream Industry in Europe
4.2.2 Demand Volume of Tuberculosis Diagnostics by Downstream Industry in Middle East
4.2.3 Demand Volume of Tuberculosis Diagnostics by Downstream Industry in Africa
4.3 Market Forecast of Tuberculosis Diagnostics in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF TUBERCULOSIS DIAGNOSTICS
5.1 EMEA Economy Situation and Trend Overview
5.2 Tuberculosis Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 TUBERCULOSIS DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Tuberculosis Diagnostics in EMEA by Major Players
6.2 Revenue of Tuberculosis Diagnostics in EMEA by Major Players
6.3 Basic Information of Tuberculosis Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Tuberculosis Diagnostics Major Players
6.3.2 Employees and Revenue Level of Tuberculosis Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 TUBERCULOSIS DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Laboratories
7.1.1 Company profile
7.1.2 Representative Tuberculosis Diagnostics Product
7.1.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.2 Becton, Dickinson and Company
7.2.1 Company profile
7.2.2 Representative Tuberculosis Diagnostics Product
7.2.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson and Company
7.3 Alere, Inc.
7.3.1 Company profile
7.3.2 Representative Tuberculosis Diagnostics Product
7.3.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Alere, Inc.
7.4 BioMerieux SA
7.4.1 Company profile
7.4.2 Representative Tuberculosis Diagnostics Product
7.4.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of BioMerieux SA
7.5 F.Hoffmann-La Roche AG
7.5.1 Company profile
7.5.2 Representative Tuberculosis Diagnostics Product
7.5.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche AG
7.6 Thermo Fisher Scientific
7.6.1 Company profile
7.6.2 Representative Tuberculosis Diagnostics Product
7.6.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.7 Siemens
7.7.1 Company profile
7.7.2 Representative Tuberculosis Diagnostics Product
7.7.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Siemens
7.8 Cepheid
7.8.1 Company profile
7.8.2 Representative Tuberculosis Diagnostics Product
7.8.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid
7.9 Akonni Biosystems
7.9.1 Company profile
7.9.2 Representative Tuberculosis Diagnostics Product
7.9.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Akonni Biosystems
7.10 Hain Lifesciences GmBH
7.10.1 Company profile
7.10.2 Representative Tuberculosis Diagnostics Product
7.10.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Hain Lifesciences GmBH
7.11 NanoEnTe
7.11.1 Company profile
7.11.2 Representative Tuberculosis Diagnostics Product
7.11.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of NanoEnTe
7.12 Hologic Corporation
7.12.1 Company profile
7.12.2 Representative Tuberculosis Diagnostics Product
7.12.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Corporation
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF TUBERCULOSIS DIAGNOSTICS
8.1 Industry Chain of Tuberculosis Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF TUBERCULOSIS DIAGNOSTICS
9.1 Cost Structure Analysis of Tuberculosis Diagnostics
9.2 Raw Materials Cost Analysis of Tuberculosis Diagnostics
9.3 Labor Cost Analysis of Tuberculosis Diagnostics
9.4 Manufacturing Expenses Analysis of Tuberculosis Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF TUBERCULOSIS DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Tuberculosis Diagnostics in This Report
1.2 Commercial Types of Tuberculosis Diagnostics
1.2.1 Smear Microscopy
1.2.2 LF-LAM For PLHIV
1.2.3 Culture
1.2.4 Molecular Testing
1.2.5 Drug Susceptibility Testing
1.2.6 Mantoux Tuberculin Testing
1.3 Downstream Application of Tuberculosis Diagnostics
1.3.1 Hospital
1.3.2 Diagnostic laboratories
1.4 Development History of Tuberculosis Diagnostics
1.5 Market Status and Trend of Tuberculosis Diagnostics 2013-2023
1.5.1 EMEA Tuberculosis Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Tuberculosis Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Tuberculosis Diagnostics in EMEA 2013-2017
2.2 Consumption Market of Tuberculosis Diagnostics in EMEA by Regions
2.2.1 Consumption Volume of Tuberculosis Diagnostics in EMEA by Regions
2.2.2 Revenue of Tuberculosis Diagnostics in EMEA by Regions
2.3 Market Analysis of Tuberculosis Diagnostics in EMEA by Regions
2.3.1 Market Analysis of Tuberculosis Diagnostics in Europe 2013-2017
2.3.2 Market Analysis of Tuberculosis Diagnostics in Middle East 2013-2017
2.3.3 Market Analysis of Tuberculosis Diagnostics in Africa 2013-2017
2.4 Market Development Forecast of Tuberculosis Diagnostics in EMEA 2018-2023
2.4.1 Market Development Forecast of Tuberculosis Diagnostics in EMEA 2018-2023
2.4.2 Market Development Forecast of Tuberculosis Diagnostics by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Tuberculosis Diagnostics in EMEA by Types
3.1.2 Revenue of Tuberculosis Diagnostics in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Tuberculosis Diagnostics in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Tuberculosis Diagnostics in EMEA by Downstream Industry
4.2 Demand Volume of Tuberculosis Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Tuberculosis Diagnostics by Downstream Industry in Europe
4.2.2 Demand Volume of Tuberculosis Diagnostics by Downstream Industry in Middle East
4.2.3 Demand Volume of Tuberculosis Diagnostics by Downstream Industry in Africa
4.3 Market Forecast of Tuberculosis Diagnostics in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF TUBERCULOSIS DIAGNOSTICS
5.1 EMEA Economy Situation and Trend Overview
5.2 Tuberculosis Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 TUBERCULOSIS DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Tuberculosis Diagnostics in EMEA by Major Players
6.2 Revenue of Tuberculosis Diagnostics in EMEA by Major Players
6.3 Basic Information of Tuberculosis Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Tuberculosis Diagnostics Major Players
6.3.2 Employees and Revenue Level of Tuberculosis Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 TUBERCULOSIS DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Laboratories
7.1.1 Company profile
7.1.2 Representative Tuberculosis Diagnostics Product
7.1.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.2 Becton, Dickinson and Company
7.2.1 Company profile
7.2.2 Representative Tuberculosis Diagnostics Product
7.2.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson and Company
7.3 Alere, Inc.
7.3.1 Company profile
7.3.2 Representative Tuberculosis Diagnostics Product
7.3.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Alere, Inc.
7.4 BioMerieux SA
7.4.1 Company profile
7.4.2 Representative Tuberculosis Diagnostics Product
7.4.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of BioMerieux SA
7.5 F.Hoffmann-La Roche AG
7.5.1 Company profile
7.5.2 Representative Tuberculosis Diagnostics Product
7.5.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche AG
7.6 Thermo Fisher Scientific
7.6.1 Company profile
7.6.2 Representative Tuberculosis Diagnostics Product
7.6.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.7 Siemens
7.7.1 Company profile
7.7.2 Representative Tuberculosis Diagnostics Product
7.7.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Siemens
7.8 Cepheid
7.8.1 Company profile
7.8.2 Representative Tuberculosis Diagnostics Product
7.8.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid
7.9 Akonni Biosystems
7.9.1 Company profile
7.9.2 Representative Tuberculosis Diagnostics Product
7.9.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Akonni Biosystems
7.10 Hain Lifesciences GmBH
7.10.1 Company profile
7.10.2 Representative Tuberculosis Diagnostics Product
7.10.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Hain Lifesciences GmBH
7.11 NanoEnTe
7.11.1 Company profile
7.11.2 Representative Tuberculosis Diagnostics Product
7.11.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of NanoEnTe
7.12 Hologic Corporation
7.12.1 Company profile
7.12.2 Representative Tuberculosis Diagnostics Product
7.12.3 Tuberculosis Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Corporation
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF TUBERCULOSIS DIAGNOSTICS
8.1 Industry Chain of Tuberculosis Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF TUBERCULOSIS DIAGNOSTICS
9.1 Cost Structure Analysis of Tuberculosis Diagnostics
9.2 Raw Materials Cost Analysis of Tuberculosis Diagnostics
9.3 Labor Cost Analysis of Tuberculosis Diagnostics
9.4 Manufacturing Expenses Analysis of Tuberculosis Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF TUBERCULOSIS DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
